ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 18 filers reported holding ARCA BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $337,000 | +23.4% | 901,611 | +10.1% | 0.00% | – |
| Q4 2018 | $273,000 | -27.2% | 818,533 | +22.1% | 0.00% | – |
| Q3 2018 | $375,000 | -24.8% | 670,459 | -29.6% | 0.00% | – |
| Q2 2018 | $499,000 | +87.6% | 952,663 | +78.6% | 0.00% | – |
| Q1 2018 | $266,000 | +52.0% | 533,413 | +311.3% | 0.00% | – |
| Q4 2017 | $175,000 | -35.7% | 129,705 | -45.2% | 0.00% | – |
| Q3 2017 | $272,000 | +109.2% | 236,726 | +335.8% | 0.00% | – |
| Q2 2017 | $130,000 | +66.7% | 54,326 | +77.4% | 0.00% | – |
| Q1 2017 | $78,000 | +41.8% | 30,626 | +59.6% | 0.00% | – |
| Q4 2016 | $55,000 | – | 19,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 231,775 | $661,000 | 0.19% |
| NEA Management Company, LLC | 1,460,209 | $4,162,000 | 0.16% |
| Tekla Capital Management LLC | 811,227 | $2,312,000 | 0.10% |
| RA Capital Management | 232,245 | $662,000 | 0.09% |
| FRANKLIN RESOURCES INC | 1,216,840 | $3,468,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,452 | $30,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,046 | $3,000 | 0.00% |
| DEUTSCHE BANK AG\ | 46,111 | $131,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 20,326 | $58,000 | 0.00% |
| MORGAN STANLEY | 4 | $0 | 0.00% |